ArticleMolecular therapy. Advances2026
The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans.
Erik Ryberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.